for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Nuvo Pharmaceuticals reports Q3 loss per share of C$0.02 from continuing operations

Nov 1 (Reuters) - Nuvo Pharmaceuticals Inc

* Nuvo Pharmaceuticals announces 2017 third quarter results

* Q3 loss per share C$0.02 from continuing operations

* Q3 revenue C$3.0 million versus C$5.5 million Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up